Article summary
This month’s edition of Competition highlights include: (1) the CMA’s decision to fine Rentokil for failing to provide documents during its phase 1 investigation; (2) the CAT’s judgment in Lebedev Holdings Limited and Another v Secretary of State for DCMS, in which it ruled that the Secretary of State was out of time to make a phase 2 public interest referral in relation to certain Evening Standard and Independent transactions; and (3) Aspen’s agreement to settle with CMA, as well as its commitment to pay the NHS £8m to NHS, regarding its participation in market-sharing for the supply of Fludrocortisone acetate tablets.
To continue reading this news article, as well as thousands of others like it, sign in with LexisNexis or register for a free trial